- Home
- ADN vs GOVX Comparison
ADN vs GOVX Comparison
Compare ADN & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADN
- GOVX
- Stock Information
- Founded
- ADN 2006
- GOVX 2001
- Country
- ADN United States
- GOVX United States
- Employees
- ADN N/A
- GOVX N/A
- Industry
- ADN Power Generation
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- ADN Utilities
- GOVX Health Care
- Exchange
- ADN Nasdaq
- GOVX Nasdaq
- Market Cap
- ADN 6.6M
- GOVX 7.6M
- IPO Year
- ADN N/A
- GOVX N/A
- Fundamental
- Price
- ADN $1.99
- GOVX $0.79
- Analyst Decision
- ADN
- GOVX Strong Buy
- Analyst Count
- ADN 0
- GOVX 4
- Target Price
- ADN N/A
- GOVX $10.50
- AVG Volume (30 Days)
- ADN 80.2K
- GOVX 2.8M
- Earning Date
- ADN 08-19-2025
- GOVX 07-28-2025
- Dividend Yield
- ADN N/A
- GOVX N/A
- EPS Growth
- ADN N/A
- GOVX N/A
- EPS
- ADN N/A
- GOVX N/A
- Revenue
- ADN $670,000.00
- GOVX $5,591,576.00
- Revenue This Year
- ADN $6,528.51
- GOVX N/A
- Revenue Next Year
- ADN N/A
- GOVX N/A
- P/E Ratio
- ADN N/A
- GOVX N/A
- Revenue Growth
- ADN N/A
- GOVX N/A
- 52 Week Low
- ADN $1.71
- GOVX $0.43
- 52 Week High
- ADN $8.79
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- ADN 43.59
- GOVX 49.37
- Support Level
- ADN $1.85
- GOVX $0.60
- Resistance Level
- ADN $2.50
- GOVX $0.88
- Average True Range (ATR)
- ADN 0.20
- GOVX 0.08
- MACD
- ADN 0.03
- GOVX 0.03
- Stochastic Oscillator
- ADN 21.54
- GOVX 68.40
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.